tirzepatide birth defects Zepbound During Pregnancy & Breastfeeding: Risks Explained 7 Common and Serious Side

Its still the right answer

Dulaglutide The AWARD-7 study assessed the efficacy and safety of dulaglutide in T2D patients with moderate-to-severe CKD (Tuttle et al., 2018)

Average statistical power considering the effect size (percent improvement in physiologic function, sample number, and level of significance) for these organs was at least 76% in these tests

The risk-benefit discussion should include GI intolerance, dehydration/renal risk, gallbladder disease, pancreatitis warning symptoms, diabetic retinopathy monitoring in some patients, hypoglycemia risk when combined with insulin/sulfonylureas, and the thyroid C-cell tumor contraindication context